Capital Flow Monitor · Sponsors · CIK 1782959

Capital Rx, Inc.

228 PARK AVENUE S., NEW YORK, NY, 10003 · 855-538-8897

Other · Corporation· inc. DELAWARE true

Fit score

—

Offering

$232.9M

Sold

$230.8M

% sold

99.1%

Investors

8

Min investment

$0

Exemption

506(b)

Filing history

FiledFormRuleOfferingSold% soldInvestors
2025-09-26 D ·current 506(b) $232.9M $230.8M 99.1% 8 EDGAR ↗

Related persons

Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.

Placement agents

  • No sales compensation reported — direct raise.

Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.